Hospital Of Oncologia Del Centro Medico Nacional Siglo Xxi

Mexico City, Mexico

Hospital Of Oncologia Del Centro Medico Nacional Siglo Xxi

Mexico City, Mexico

Time filter

Source Type

Borja-Aburto V.H.,Instituto Mexicano del Seguro Social | Davila-Torres J.,Instituto Mexicano del Seguro Social | Rascon-Pacheco R.A.,Instituto Mexicano del Seguro Social | Gonzalez-Leon M.,Instituto Mexicano del Seguro Social | And 4 more authors.
Salud Publica de Mexico | Year: 2016

Objective: To analyze cancer mortality in affiliates of the Mexican Social Security Institute (Instituto Mexicano del Seguro Social-IMSS) and time trends in the risk of death due to cancer from 1989 to 2013. Materials and methods: A descriptive analysis of cancer mortality trends in beneficiaries of the IMSS was performed. Age- and sex-adjusted mortality rates were obtained using direct standardization with the WHO population. Changes in the risk of death due to cancer over time were evaluated using Poisson regression. Results: The absolute number of deaths due to cancer doubled from 1989 to 2013 due to increasing age of the affiliate population. The risk of death among affiliates decreased for the majority of cancers except for colon and rectal cancer. Conclusion: The risk of dying from cancer among IMSS affiliates showed a marked decrease, which may be due to an increase in detection and opportune treatment.


Vargas-Aguilar V.M.,Hospital Of Oncologia Del Centro Medico Nacional Siglo Xxi | Quijano-Castro O.F.,Hospital Of Oncologia Del Centro Medico Nacional Siglo Xxi | Rocha-Guevara E.R.,Hospital Of Oncologia Del Centro Medico Nacional Siglo Xxi | Vargas-Hernandez V.M.,Hospital Of Gineco Obstetricia Del Centro Medico Nacional La Raza
Clinica e Investigacion en Ginecologia y Obstetricia | Year: 2016

Background: Treatment for ovarian cancer consists of primary cytoreductive surgery and platinum-based adjuvant chemotherapy. Most patients are diagnosed when the disease is at an advanced stage. Surgery for recurrent disease is not associated with increased overall survival. Intraperitoneal chemotherapy exposes tumoural tissue to high doses within the peritoneal cavity. Perioperative morbidity, toxicity, and the effects of hyperthermia have not been established. The morbidity and mortality associated with ultraradical cytoreductive surgery and intraperitoneal chemotherapy are high and may be directly due to the surgery, the chemotherapy, or both. Studies have reported morbidity and mortality rates of 0% to 43% and 0% to 20%, respectively. Material and method: An observational, retrospective, non-experimental, descriptive study was carried out in patients with advanced or recurrent ovarian cancer treated with cytoreductive surgery with total or partial peritonectomy and intraperitoneal chemotherapy. A descriptive statistical analysis was performed with measurement of central tendency and dispersion. Results: Perioperative mortality was 0%. One patient with intestinal resection and pelvic peritonectomy developed complications with deep venous thrombosis and abdominal sepsis due to colorectal anastomotic dehiscence. No patients developed complications due to intraperitoneal chemotherapy. Conclusions: The morbidity and mortality rates associated with total or partial peritonectomy with intraperitoneal chemotherapy in our institution are similar to those reported in other institutions. © 2016 Elsevier España, S.L.U.

Loading Hospital Of Oncologia Del Centro Medico Nacional Siglo Xxi collaborators
Loading Hospital Of Oncologia Del Centro Medico Nacional Siglo Xxi collaborators